Skip to content
HowShorted

EyePoint, Inc. short interest in 2024

In 2024, EyePoint, Inc.'s disclosed short interest ran from 14.74% of shares outstanding on 12 Jan 2024 to 15.15% on 31 Dec 2024, a change of +0.41 percentage points. The year's high was 20.23% on 15 Jul 2024 and its low 13.12% on 15 Apr 2024, averaging 15.73% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 20.16 days on 30 Aug 2024. Full history: EyePoint, Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for EyePoint, Inc. in 2024

2024 in figures

Start of year
14.74% (12 Jan 2024)
End of year
15.15% (31 Dec 2024)
Change
+0.41 pp
High
20.23% (15 Jul 2024)
Low
13.12% (15 Apr 2024)
Average
15.73%
Highest days to cover
20.16 (30 Aug 2024)
SEC filings marked
11

Every report in 2024

EyePoint, Inc. short interest in 2024
SettlementShort interestDays to coverFilings since previous
12 Jan 202414.74%4.89results (8-K)
31 Jan 202414.54%5.21
15 Feb 202413.45%4.51
29 Feb 202416.21%5.30
15 Mar 202413.20%5.51results (8-K), 10-K filed
28 Mar 202413.74%10.26
15 Apr 202413.12%11.63
30 Apr 202413.25%5.30
15 May 202416.32%3.82results (8-K), 10-Q filed
31 May 202415.54%9.04
14 Jun 202418.03%8.98
28 Jun 202419.32%10.07results (8-K)
15 Jul 202420.23%11.70
31 Jul 202419.16%13.97
15 Aug 202417.71%12.74results (8-K), 10-Q filed
30 Aug 202417.03%20.16
13 Sep 202417.01%15.31
30 Sep 202416.69%14.22
15 Oct 202417.14%17.64
31 Oct 202414.18%7.26results (8-K)
15 Nov 202414.47%14.1010-Q filed, results (8-K)
29 Nov 202413.55%8.53
13 Dec 202413.79%10.78
31 Dec 202415.15%11.17

See also: EyePoint, Inc.'s full history · most shorted US stocks of 2024 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.